Literature DB >> 25765829

Pharmacological synergism of bee venom and melittin with antibiotics and plant secondary metabolites against multi-drug resistant microbial pathogens.

Issam Al-Ani1, Stefan Zimmermann2, Jürgen Reichling3, Michael Wink4.   

Abstract

The goal of this study was to investigate the antimicrobial activity of bee venom and its main component, melittin, alone or in two-drug and three-drug combinations with antibiotics (vancomycin, oxacillin, and amikacin) or antimicrobial plant secondary metabolites (carvacrol, benzyl isothiocyanate, the alkaloids sanguinarine and berberine) against drug-sensitive and antibiotic-resistant microbial pathogens. The secondary metabolites were selected corresponding to the molecular targets to which they are directed, being different from those of melittin and the antibiotics. The minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) were evaluated by the standard broth microdilution method, while synergistic or additive interactions were assessed by checkerboard dilution and time-kill curve assays. Bee venom and melittin exhibited a broad spectrum of antibacterial activity against 51 strains of both Gram-positive and Gram-negative bacteria with strong anti-MRSA and anti-VRE activity (MIC values between 6 and 800 µg/ml). Moreover, bee venom and melittin showed significant antifungal activity (MIC values between 30 and 100 µg/ml). Carvacrol displayed bactericidal activity, while BITC exhibited bacteriostatic activity against all MRSA and VRE strains tested (reference strains and clinical isolates), both compounds showed a remarkable fungicidal activity with minimum fungicidal concentration (MFC) values between 30 and 200 µg/ml. The DNA intercalating alkaloid sanguinarine showed bactericidal activity against MRSA NCTC 10442 (MBC 20 µg/ml), while berberine exhibited bacteriostatic activity against MRSA NCTC 10442 (MIC 40 µg/ml). Checkerboard dilution tests mostly revealed synergism of two-drug combinations against all the tested microorganisms with FIC indexes between 0.24 and 0.50, except for rapidly growing mycobacteria in which combinations exerted an additive effect (FICI = 0.75-1). In time-kill assays all three-drug combinations exhibited a powerful bactericidal synergistic effect against MRSA NCTC 10442, VRE ATCC 51299, and E. coli ATCC 25922 with a reduction of more than 3log10 in the colony count after 24 h. Our findings suggest that bee venom and melittin synergistically enhanced the bactericidal effect of several antimicrobial agents when applied in combination especially when the drugs affect several and differing molecular targets. These results could lead to the development of novel or complementary antibacterial drugs against MDR pathogens.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Bee venom; Benzyl isothiocyanate; Berberine; Carvacrol; Melittin; Sanguinarine

Mesh:

Substances:

Year:  2015        PMID: 25765829     DOI: 10.1016/j.phymed.2014.11.019

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  26 in total

1.  Lipid topology and electrostatic interactions underpin lytic activity of linear cationic antimicrobial peptides in membranes.

Authors:  David J Paterson; Manlio Tassieri; Julien Reboud; Rab Wilson; Jonathan M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-20       Impact factor: 11.205

2.  Reducing Virulence and Biofilm of Pseudomonas aeruginosa by Potential Quorum Sensing Inhibitor Carotenoid: Zeaxanthin.

Authors:  Barış Gökalsın; Busecan Aksoydan; Burak Erman; Nüzhet Cenk Sesal
Journal:  Microb Ecol       Date:  2017-03-02       Impact factor: 4.552

3.  Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.

Authors:  Chiu-Fai Kuok; Sai-On Hoi; Chi-Fai Hoi; Chi-Hong Chan; Io-Hong Fong; Cheong-Kei Ngok; Li-Rong Meng; Pedro Fong
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

4.  Highly Synergistic Effects of Melittin With Vancomycin and Rifampin Against Vancomycin and Rifampin Resistant Staphylococcus epidermidis.

Authors:  Rasoul Mirzaei; Mohammad Yousef Alikhani; Carla Renata Arciola; Iraj Sedighi; GholamReza Irajian; Elaheh Jamasbi; Rasoul Yousefimashouf; Kamran Pooshang Bagheri
Journal:  Front Microbiol       Date:  2022-06-23       Impact factor: 6.064

5.  Lichen secondary metabolite evernic acid as potential quorum sensing inhibitor against Pseudomonas aeruginosa.

Authors:  Barış Gökalsın; Nüzhet Cenk Sesal
Journal:  World J Microbiol Biotechnol       Date:  2016-07-27       Impact factor: 3.312

6.  Green synthesis of titanium dioxide nanoparticles with volatile oil of Eugenia caryophyllata for enhanced antimicrobial activities.

Authors:  Raghad Dhyea Abdul Jalill
Journal:  IET Nanobiotechnol       Date:  2018-08       Impact factor: 1.847

7.  Chemical Profiling and Antimicrobial Properties of Honey Bee (Apis mellifera L.) Venom.

Authors:  Irina Tanuwidjaja; Lidija Svečnjak; Domenika Gugić; Marko Levanić; Slaven Jurić; Marko Vinceković; Mirna Mrkonjić Fuka
Journal:  Molecules       Date:  2021-05-20       Impact factor: 4.411

Review 8.  Promising Antimicrobial Properties of Bioactive Compounds from Different Honeybee Products.

Authors:  Magdalena Ratajczak; Dorota Kaminska; Eliza Matuszewska; Elżbieta Hołderna-Kedzia; Jarosław Rogacki; Jan Matysiak
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

Review 9.  Cheminformatic Characterization of Natural Antimicrobial Products for the Development of New Lead Compounds.

Authors:  Samson Olaitan Oselusi; Alan Christoffels; Samuel Ayodele Egieyeh
Journal:  Molecules       Date:  2021-06-29       Impact factor: 4.411

Review 10.  Challenge in the Discovery of New Drugs: Antimicrobial Peptides against WHO-List of Critical and High-Priority Bacteria.

Authors:  Cesar Augusto Roque-Borda; Patricia Bento da Silva; Mosar Corrêa Rodrigues; Ricardo Bentes Azevedo; Leonardo Di Filippo; Jonatas L Duarte; Marlus Chorilli; Eduardo Festozo Vicente; Fernando Rogério Pavan
Journal:  Pharmaceutics       Date:  2021-05-21       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.